Literature DB >> 21913347

The damage patterns of retinal nerve fiber layer in acute and chronic intraocular pressure elevation in primary angle closure glaucoma.

Xing Liu1, Mei Li, Yimin Zhong, Hui Xiao, Jingjing Huang, Zhen Mao.   

Abstract

PURPOSE: To observe the differences of damage patterns of retinal nerve fiber layer (RNFL) between acute and chronic intraocular pressure (IOP) elevation in primary angle closure glaucoma (PACG) using optical coherence tomography (OCT).
METHODS: Twenty four patients (48 eyes) with unilateral acute PACG (APACG) attack in the 6 months after remission and 36 patients (64 eyes) with chronic PACG (CPACG) were included in this prospective study. For all cases, IOP has been controlled less than 21 mm Hg after treatment. Using stratus OCT, the RNFL thickness was assessed in eyes with PACG within 3 days, 2 weeks, 1, 3 and 6 month after IOP controlled. Repeated measures ANOVA was used to examine the time course of changes after IOP controlled in RNFL thickness in both acute attack and unaffected fellow eyes of APACG and eyes with CPACG.
RESULTS: The mean RNFL thickness (μm) for the APACG-attacked eyes increased significantly within 3 days (121.49±23.84) after acute strike and then became thinner along with time (107.22±24.72 at 2 week, 93.58±18.37 at 1 month, 84.10±19.89 at 3 month and 78.98±19.17 at 6 month). In APACG-attacked eyes, there were significant differences of average RNFL thickness among 5 different times after IOP was controlled (P < 0.001). In the APACG unaffected fellow eyes and CPACG eyes, there were no significant differences in mean RNFL thickness among 5 different times (F = 0.450, P = 0.104 in APACG unaffected fellow eyes and F = 1.558, P = 0.200 in CPACG eyes). There was significant difference for interaction between time periods and groups (F = 1.912,P = 0.003).
CONCLUSION: RNFL damage patterns are different under different IOP elevated courses. In APACG, RNFL was found to be swollen and thickening right after acute attack and then becomes thinning and atrophy along with the time, while RNFL was found to be diffused thinness in CPACG.

Entities:  

Mesh:

Year:  2011        PMID: 21913347     DOI: 10.3969/j.issn.1000-4432.2011.03.006

Source DB:  PubMed          Journal:  Eye Sci


  6 in total

1.  Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study.

Authors:  Masoud Soheilian; Saeed Karimi; Talieh Montahae; Homayoun Nikkhah; Seyed Aliasghar Mosavi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-14       Impact factor: 3.117

2.  Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats.

Authors:  Carla J Abbott; Tiffany E Choe; Theresa A Lusardi; Claude F Burgoyne; Lin Wang; Brad Fortune
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-04       Impact factor: 4.799

3.  Potentially Missed Opportunities in Prevention of Acute Angle-Closure Crisis.

Authors:  Annie M Wu; Joshua D Stein; Manjool Shah
Journal:  JAMA Ophthalmol       Date:  2022-06-01       Impact factor: 8.253

4.  Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection.

Authors:  Jocelyn Lam; Ian Luttrell; Leona Ding; Kasra Rezaei; Jennifer R Chao; Yewlin Chee; Lisa C Olmos De Koo; Joanne C Wen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-06       Impact factor: 3.117

5.  Changes of Neuroretinal Rim and Retinal Nerve Fiber Layer Thickness Assessed by Optical Coherence Tomography After Filtration Surgery in Glaucomatous Eyes.

Authors:  Susanna Friederike Koenig; Christoph Wolfgang Hirneiss
Journal:  Clin Ophthalmol       Date:  2021-06-03

6.  Ocular parameters before and after steep Trendelenburg positioning for robotic-assisted laparoscopic radical prostatectomy.

Authors:  Kyoichi Mizumoto; Masahiko Gosho; Masayoshi Iwaki; Masahiro Zako
Journal:  Clin Ophthalmol       Date:  2017-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.